A compromised vitamin D status, characterized by low 25-hydroxyvitamin D (25-(OH)D) serum levels, and a nutritional calcium deficit are widely encountered in European and North American countries, independent of age or gender. Both conditions are linked to the pathogenesis of many degenerative, malignant, inflammatory and metabolic diseases. Studies on tissue-specific expression and activity of vitamin D metabolizing enzymes, 25-(OH)D-1a-hydroxylase and 25-(OH)D-24-hydroxylase, and of the extracellular calcium-sensing receptor (CaR) have led to the understanding of how, in non-renal tissues and cellular systems, locally produced 1,25-dihydroxyvitamin D 3 (1,25-(OH) 2 D 3 ) and extracellular Ca 2 þ act jointly as key regulators of cellular proliferation, differentiation and function. Impairment of cooperative signalling from the 1,25-(OH) 2 D 3 -activated vitamin D receptor (VDR) and from the CaR in vitamin D and calcium insufficiency causes cellular dysfunction in many organs and biological systems, and, therefore, increases the risk of diseases, particularly of osteoporosis, colorectal and breast cancer, inflammatory bowel disease, insulin-dependent diabetes mellitus type I, metabolic syndrome, diabetes mellitus type II, hypertension and cardiovascular disease. Understanding the underlying molecular and cellular processes provides a rationale for advocating adequate intake of vitamin D and calcium in all populations, thereby preventing many chronic diseases worldwide.
Introduction
In a previous review on the significance of vitamin D and calcium insufficiency as risk factors of multiple chronic diseases (Peterlik and Cross, 2005) , we had put forward the notion that reduced local synthesis of 1, 25-dihydroxyvitamin D 3 (1,25-(OH) 2 D 3 ) in non-renal tissues as well as attenuated signalling from extracellular Ca 2 þ through the calcium-sensing receptor (CaR) could explain why a compromised vitamin D status and low habitual calcium intake predispose not only for osteoporosis but also for various malignancies, chronic inflammatory and autoimmune diseases, hypertension and metabolic disorders. Recently, additional major diseases were identified to be vitamin D and calcium insufficiency-related, such as cancer in general, incidence and mortality of cardiovascular disease and all-cause mortality. Large epidemiological studies strongly indicate that combined supplementation of vitamin D and calcium is necessary for efficient disease prevention. This and new insights into molecular and cellular mechanisms of vitamin D, and calcium action and interaction in homeostatic control of cellular functions prompted us to write an up-to-date review, focussing on the role of calcium and vitamin D insufficiencies as interrelated risk factors for the most frequent chronic diseases occurring worldwide.
Hypovitaminosis D and nutritional calcium insufficiency
Hypovitaminosis D denotes a compromised vitamin D status that results from an insufficient supply of vitamin D, which is reflected by low serum levels of 25-hydroxyvitamin D (25-(OH)D); the term 25-(OH)D is used to denote the sum of 25-(OH)D 3 and 25-(OH)D 2 , the latter from dietary sources. Outright vitamin D deficiency is indicated by plasma 25-(OH)D levels below B15 nM. In this situation, 1,25-(OH) 2 D 3 production in the kidney is severely limited because of substrate depletion. This, in turn, causes a decrease in intestinal calcium absorption, with rickets or osteomalacia as a consequence. At 25-(OH)D serum concentrations above 15 nM, the kidney produces enough 1,25-(OH) 2 D 3 to maintain systemic mineral ion homeostasis (Hansen et al., 2008) , but availability of 25-(OH)D for intracellular production of 1,25-(OH) 2 D 3 at extra-renal sites may be insufficient for autocrine/paracrine control of cellular functions (Peterlik and Cross, 2005) . By conservative calculations, the set point between vitamin D insufficiency and optimal vitamin D is B30 nM 25-(OH)D (Chapuy et al., 1997) . However, for optimal health outcomes serum 25-(OH)D levels should be maintained at between 60 and 100 nM (Bischoff-Ferrari et al., 2006a) . Vitamin D and calcium insufficiencies are common phenomena in otherwise healthy adults of both genders in many European countries and in North America. The term 'calcium insufficiency' is used to describe a condition, which, as a result of low habitual calcium intake, can be linked to an increased risk of multiple chronic diseases (for review, see Peterlik and Cross, 2005) .
Vitamin D and calcium actions: molecular and cellular aspects
Relevance of extra-renal vitamin D synthesis for local homeostatic control of cell functions Figure 1 illustrates the steps in the conversion of vitamin D 3 to 1,25-(OH) 2 D 3 . The biological importance of 1,25-(OH) 2 D 3 is highlighted by the fact that many cell types are endowed with the vitamin D receptor (VDR), which functions as a ligand-activated transcription factor to mediate the genomic effects of the hormone. Conversion of 25-(OH)D 3 to 1,25-(OH) 2 D 3 is catalyzed by the CYP27B1-encoded enzyme 25-(OH)D-1a-hydroxylase and occurs primarily in the kidney. However, many extra-renal cells also biosynthesize 1,25-(OH) 2 D 3 (Hewison et al., 2007) . Renal 25-(OH)D-1a-hydroxylase is tightly regulated by serum Ca 2 þ and parathyroid hormone (PTH), as well as by feed-back inhibition from 1,25-(OH) 2 D 3 (Figure 1 ). Therefore, circulating 1,25-(OH) 2 D 3 can be maintained in the normal range, even when serum levels of 25-(OH)D are relatively low (Hansen et al., 2008) . However, extra-renal 25-(OH)D-1a-hydroxylase activity is relatively insensitive to PTH and extracellular Ca 2 þ (Kallay et al., 2005; van Driel et al., 2006) , and depends largely on ambient 25-(OH)D levels (Anderson et al., 2005; Lechner et al., 2007) (cf. Figure 1 ). This may explain why the incidence of vitamin D insufficiency-related chronic diseases is correlated with low serum 25-(OH)D, but not with 1,25-(OH) 2 D 3 . This has been shown for osteoporosis (Chapuy et al., 1992) as well as for cancer, particularly of the colorectum (Feskanich et al., 2004) , breast (Bertone-Johnson et al., 2005) and prostate gland (Tuohimaa et al., 2004 Atkins et al. (2007) showed that human osteoblasts express megalin and, when treated with 25-(OH)D 3 , produce sufficient 1,25-(OH) 2 D 3 to induce typical expression of osteocalcin, osteopontin and RANKL (receptor activator for nuclear factor k B ligand). In addition, Lechner et al. (2007) could induce the characteristic anti-mitogenic effect of 1,25-(OH) 2 D 3 when 25-(OH)D-1a-hydroxylase positive human colon carcinoma cells were treated with 25-(OH)D 3 . Altogether, at low serum levels of 25-(OH)D, 25-(OH)D-1a-hydroxylase activity in extra-renal cellular systems may be not high enough to achieve steady-state tissue concentrations of 1,25-(OH) 2 D 3 , necessary to regulate cellular growth, differentiation and function. Therefore, vitamin D insufficiency may have an important pathogenic role in malignant, inflammatory, autoimmune and metabolic diseases (Peterlik and Cross, 2005) . Importantly, a compromised vitamin D status has been identified as an independent predictor of overall mortality .
Role of the extracellular CaR in control of cellular functions
There is evidence from many human and animal studies for a significant inverse relationship between dietary calcium intake and risk of multiple chronic diseases (Peterlik and Cross, 2005) . This is difficult to understand because the effect of even large variations in calcium intake levels on extracellular calcium concentrations [Ca 2 þ ] o is attenuated (Dvorak et al., 2004; Brown and Lian, 2008; Chang et al., 2008) , as well as in limitation of cellular growth of normal and neoplastic cells (Rodland, 2004) . Conversely, low dietary calcium causes hyperparathyroidism by impairment of CaR activity and, by the same token, can be linked to the development of osteoporosis and of various malignancies. Whether and how the CaR can be implicated in the pathogenesis of other calcium insufficiency-related chronic diseases is still a matter of discussion.
Vitamin D and calcium actions and interactions: pathophysiological aspects
Skeletal diseases Rickets and osteomalacia. The important function of vitamin D in preventing rickets and osteomalacia has been attributed to the stimulatory effect of 1,25-(OH) 2 D 3 on transcellular calcium and phosphate absorption. However, it has to be taken into consideration that mineralization of the organic matrix, once produced by growth factor-stimulated osteoprogenitor cells, depends primarily on their further maturation into differentiated osteoblasts. This process is tightly controlled by VDR-mediated effects of 1,25-(OH) 2 D 3 on temporal expression of genes coding for the non-collagenous matrix proteins, which are necessary for initiation of the mineralization process (Owen et al., 1991) . Osteoblasts are an important source of 1,25-(OH) 2 D 3 , because they exhibit 25-(OH)D-1a-hydroxylase activity (Atkins et al., 2007) . In vitamin D deficiency, however, a lack of endogenously produced 1,25-(OH) 2 D 3 may retard osteoblast differentiation and, therefore, also mineralization of the organic matrix.
Osteoporosis. Vitamin D insufficiency and calcium malnutrition are of significance for the development of involutional osteoporosis in both genders. This is illustrated by, among others, a recent report from Looker and Mussolino, (2008) that hip fractures in older adults were associated with low serum levels of 25-(OH)D and calcium. Both vitamin D 3 and calcium are required to prevent and treat osteoporosis (Boonen et al., 2007) . This can be explained by the fact that signalling from Ca 2 þ /CaR and 1,25-(OH) 2 D 3 /VDR have to interact in a cell-specific manner to promote mineralized bone formation. As illustrated in Figure 2 , activation of the CaR by an increase in extracellular Ca 2 þ first seems to stimulate pre-osteoblasts to proliferate (Yamaguchi et al., 1998a) and to produce collagen. Then, signalling from 1,25-(OH) 2 D 3 /VDR promotes osteoblast differentiation through phases of matrix maturation and mineralization (Owen et al., 1991) . At this stage, signalling from the CaR seems to be particularly important for orderly bone formation by regulating crystal growth and preventing excessive mineralization (Dvorak et al., 2004) . Low 25-(OH)D is detrimental for bone health, not only because it impairs osteoblast differentiation but also because it leads to secondary hyperparathyroidism. Particularly in the elderly, serum 25-(OH)D levels are inversely correlated with PTH secretion (Kudlacek et al., 2003) . One explanation for this phenomenon could be that in vitamin D insufficiency, CYP27B1-mediated production of 1,25-(OH) 2 D 3 in parathyroid gland cells is too low to effectively suppress PTH secretion (Ritter et al., 2006) and action on osteoclasts. Pilz et al. (2008) found that low serum 25-(OH)D levels predict fatal cancer in general. A particularly strong association between a low vitamin D status and cancer incidence or mortality has been reported for colon, rectal, breast, prostate and ovarian cancer. In addition, vitamin D insufficiency apparently contributes to the pathogenesis of gastric, lung, esophageal, pancreatic, renal and endometrial cancer, as well as for non-Hodgkin's lymphoma (Grant and Garland, 2006) . There is evidence that poor calcium nutrition is a significant risk factor for colorectal (Cho et al., 2004) , breast (Lin et al., 2007) and renal (Prineas et al., 1997) cancers.
Cancer
There are multiple evidences that calcium and vitamin D status act together in the pathogenesis of cancer in general. Vitamin D, calcium and chronic diseases M Peterlik and HS Cross Lappe et al. (2007) showed that only combined calcium and vitamin D supplements could significantly reduce the cumulative incidence of cancer of the breast, lung, colon and uterus, as well as of the lymphoid and myeloid system. In particular, Cho et al. (2004) concluded from an analysis of pooled primary data from 10 cohort studies that optimal risk reduction for colorectal cancer necessitates high intake levels of both vitamin D and calcium. Berube et al. (2005) studied the relation of separate and combined intakes of vitamin D and calcium by pre-menopausal women on mammographic breast density as a surrogate marker for breast cancer risk. They found that the negative association between dietary vitamin D intake and breast density tended to be stronger when calcium intake levels were higher and vice versa.
1,25-(OH) 2 D 3 exerts anti-proliferative effects on cancer cells by modulating the transcriptional activity of key genes involved in cell cycle control (for review, see Deeb et al., 2007) . 1,25-(OH) 2 D 3 may also suppress tumor growth and progression indirectly by facilitating immunocytotoxic killing of tumor cells: 1,25-(OH) 2 D 3 reduces levels of immunosuppressive CD34 þ lymphocytes, which normally limit the cytotoxic activity of infiltrating tumor-specific CD8 þ T-lymphocytes (Wiers et al., 1998) . The nearly ubiquitous expression of CYP27B1 and the importance of intrinsic 1,25-(OH) 2 D 3 production to control cell proliferation may explain why vitamin D insufficiency increases the risk of malignancies in many organs and biological systems. The CaR is an essential part of an intricate network of Ca 2 þ -signalling pathways that control normal and cancer cell growth (Capiod et al., 2007) . Depending on cell-specific coupling to appropriate G-proteins, activation of the CaR by elevated extracellular Ca 2 þ reduces the rate of cellular proliferation, as seen in human colon carcinoma (Kallay et al., 2003; Chakrabarty et al., 2005) or ovarian surface epithelial cells (Bilderback et al., 2002) , but may also stimulate cell growth, as seen in malignant Leydig cells , and protect from apoptosis, for example, in prostate cancer cells (Lin et al., 1998) .
Colorectal cancer. Studies from our laboratory have shown that 1,25-(OH) 2 D 3 inhibits growth and promotes differentiation of human colon adenoma and carcinoma cells by inhibiting upregulation of cyclin D1 expression, a key element in cell cycle control (Cross and Kallay, 2009) . A number of intracellular proliferative signalling pathways, namely, the Raf-1/MEK1 (MAPK/ERK kinase)/ERK (extracellular signal-regulated kinase) and STAT-3 (signal transducer and activator of transcription 3) pathways, converge at c-myc and engage cyclin D1 as a common downstream effector. 1,25-(OH) 2 D 3 , therefore, counteracts mitogenesis, whatever the nature of cellular growth promoting factors is. A role of the CaR in mediating the chemopreventive effects of calcium was suggested by the significant association between genetic variants of the CaR and advanced colorectal adenoma (Peters et al., 2004) . Moreover, certain single nucleotide polymorphisms in the CaR gene were found to be associated with an increased risk of cancer in the proximal colon (Dong et al., 2008) . Neoplastic human colonocytes express CaR at the mRNA and protein levels, as long as they retain a certain degree of differentiation. CaR activation causes downregulation of c-myc proto-oncogene expression (Kallay et al., 1997) and subsequent cell cycle arrest at the G 1 /S-phase transition (Kallay et al., 2003) . triggers calpain-mediated caspase-independent programmed cell death (Mathiasen et al., 2002) .
A role for functional CaR in breast cancer can be inferred from the fact that in pre-menopausal women, the serum calcium levels vary inversely with breast cancer risk in a concentration-dependent manner (Almquist et al., 2007) . Both normal and malignant mammary gland epithelial cells are endowed with the CaR (Cheng et al., 1998) (Tuohimaa et al., 2004) , rather conflicting data have been reported on the effect of calcium intake. Huncharek et al. (2008) found that calcium data from cohort studies were heterogenous. However, case-control analyses showed no association between calcium and increased risk of prostate cancer. The discordant findings on the influence of calcium on prostate cancer risk may be better understood if one considers the possibility of a dual effect of CaR activation on prostate epithelial cell growth. It is not clear whether activation of the CaR on prostate epithelial cells by high calcium will only inhibit cell growth. Owing to transactivation, by the CaR, of the epidermal growth factor receptor (Yano et al., 2004b) , high calcium could also induce proliferation and prevent apoptosis. We hypothesize that depending on the outcome of CaR-mediated growth modulation, calcium intake could be associated with an increased risk, with no risk or even with a reduced risk of prostate cancer.
Renal cancer. Of other vitamin D-sensitive malignancies, only renal cancer shows a significant inverse relation between incidence and total dietary calcium intake (Prineas et al., 1997) .
Infectious diseases
There is a wealth of evidence suggesting that vitamin D is a potent regulator of innate immune responses against infectious diseases (Adams and Hewison, 2008) , caused particularly by Mycobacterium tuberculosis (Martineau et al., 2007) and Gram-negative bacteria (Equils et al., 2006) . Of paramount importance for the role of vitamin D in innate immunity is the fact that monocytes, macrophages and dendritic cells express the VDR and are endowed with 25-(OH)D-1a-hydroxylase activity (Hewison et al., 2007 ). An important mechanism of anti-microbial action of 1a,25-(OH) 2 D 3 was recently described by Liu et al. (2006) : Activation of toll-like receptors-2/1 on human macrophages by microbe-associated proteins cause upregulation of VDR and CYP27B1. In turn, intracellularly produced 1,25-(OH) 2 D 3 induces release of LL-37, a potent anti-microbial peptide from the cathelicidin family. For example, upregulation of the cathelicidin hCAP-18 gene, rather than stimulation of nitric oxide formation, is the major mechanism by which 1,25-(OH) 2 D 3 protects against tuberculosis (Martineau et al., 2007) . The stimulatory action of 1,25-(OH) 2 D 3 on LL-37 release is not only limited to monocytes and macrophages but also occurs in epithelial cells. This can be of importance in skin injury, because also in keratinocytes, signalling from toll-like receptors upregulates 25-(OH)D-1a-hydroxylase activity, in turn causing increased LL-37 cathelicidin production (Schauber et al., 2007) . It is evident, therefore, that only at high 25-(OH)D concentrations, keratinocytes can produce enough 1,25-(OH) 2 D 3 to muster an effective LL-37-mediated anti-microbial response that protects against wound infection.
A specific role of extracellular calcium in the innate immune system can be inferred from its actions on monocytic cells. Olszak et al. (2000) showed that a functional CaR on peripheral blood monocytes (Yamaguchi et al., 1998b) transduces a rise in ambient calcium into a chemotactic response to the chemokine MCP-1 (monocyte chemoattractant protein 1). It does so by upregulating its cognate receptor, CCR2 (chemokine (C-C motif) receptor 2). MCP-1 in turn stimulates expression of the CaR and thereby augments recruitment of immunocompetent cells. This explains why, for example, combined calcium and vitamin D supplements can prevent or ameliorate chronic infections, such as gingivitis and periodontitis (Hildebolt, 2005) , and can thus help minimize tooth loss at advanced age (Krall et al., 2001) .
Chronic inflammatory and autoimmune diseases
A compromised vitamin D status increases the risk for autoimmune diseases, such as inflammatory bowel disease (IBD), rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type I diabetes mellitus. This phenomenon can be correlated with the reduced capability of immune cells to produce 1,25-(OH) 2 D 3 , so that the immunomodulatory and anti-inflammatory actions of the hormone are severely compromised (Hewison et al., 2007) .
1,25-(OH) 2 D 3 has an important role in the immune system by modulating T lymphocyte growth, differentiation and function (Hewison et al., 2007 þ T helper (Th-0) into Th-1 cells. Thereby, the hormone reduces the number of CD4 þ cells that produce IL-2, the cytotoxic T-cell proliferation factor, as well as the proinflammatory cytokines, TNF-a (tumor necrosis factor-alpha) and IFN-g (interferon-gamma) (Thien et al., 2005 (Loser et al., 2006) , the hormone may increase the number of IL-10-producing T reg cells and/or augment their secretion of IL-10, which inhibits inflammatory T-cell activation (Spach et al., 2006) . A link between inadequate calcium supply and a specific infectious or chronic inflammatory disease in humans has not yet been established, even though experimental animal studies provide evidence for an essential role of calcium in suppression of autoimmune responses. For example, defects in immune cell functions in experimental animals that result from disruption of 1,25-(OH) 2 D 3 /VDR signalling can be fully restored if calcium homeostasis is normalized. This indicates that the function of 1,25-(OH) 2 D 3 in the immune system is redundant and can be substituted by calcium (Mathieu et al., 2001; Zhu et al., 2005) .
Inflammatory bowel disease. Inflammatory bowel disease develops in individuals with a genetic disposition for a polarized immune response in the Th-1 direction. The sustained release of pro-inflammatory cytokines, such as TNF-a, IFN-g or IL-6, causes a chronic, relapsing and remitting inflammatory condition that leads to gut dysfunction and mucosal injury. A protective role of vitamin D against damage from inflammatory reactions can be implied from studies using mice, which were genotypically altered to abrogate VDR-mediated signalling from 1,25-(OH) 2 D 3 : the colon mucosa of VDR-knockout (VDR À/À ) mice showed a pattern of increased formation of reactive oxygen species, DNA damage and cell division (Kallay et al., 2001) , which resembled the typical focal inflammatory and hyperproliferative lesions in incipient ulcerative colitis. In the IL-10 knockout mouse model of chronic colitis, lack of VDR expression aggravates typical symptoms of IBD (Froicu et al., 2003) . Of relevance for the protective role of 1,25-(OH) 2 D 3 against IBD is the fact that there exists a local vitamin D endocrine system in the gut, consisting of immune cells and mucosal epithelial cells, both of which convert 25-(OH)D into 1,25-(OH) 2 D 3 by CYP27B1-catalyzed hydroxylation (Cross et al., 1997; Hewison et al., 2007) .
A preventive effect of high calcium intake on IBD is suggested by animal studies. High dietary calcium reduced the severity of IBD symptoms in an IL-10 knockout mouse model of chronic colitis by inhibiting TNF-a production in inflammatory lesions (Zhu et al., 2005) . The observation that reduction of dietary calcium raises the activity of the inflammatory marker COX-2 in the large intestinal epithelium in mice (Nittke et al., 2008) indicates that extracellular calcium can inhibit an anti-inflammatory response downstream of TNF-a receptor activation. In addition, high luminal calcium reduces the extent of 25-(OH)D-24-hydroxylase-mediated catabolism of 1,25-(OH) 2 D 3 in the large intestine (Kallay et al., 2005) .
Diabetes mellitus type I. Many animal studies indicate that vitamin D deficiency facilitates the development of insulindependent diabetes mellitus (for review, see Mathieu and Badenhoop, 2005) . The importance of vitamin D supplementation for the prevention of diabetes mellitus type I in humans is highlighted by the study of Hypponen et al. (2001) , which showed that regular vitamin D 3 intake during the first year of life is associated with an 88% risk reduction of autoimmune diabetes mellitus in later life. 1,25-(OH) 2 D 3 may help prevent diabetes by stimulating insulin secretion, suppressing insulitis-associated inflammatory chemokine release, and by inhibiting recruitment and function of autoaggressive T lymphocytes (Giarratana et al., 2004) A positive role of calcium in preventing insulin-dependent diabetes mellitus is indicated by animal studies (Mathieu et al., 2001) . Moreover, the presence of a functional CaR on human pancreatic b-cells (Squires et al., 2000) suggests that these cells can react to changes in extracellular Ca 2 þ .
However, direct evidence for the CaR-modulating insulin secretion from the human pancreas is still missing.
Hypertension
Results from three large prospective cohort studies indicate that low vitamin D intake is not associated with an increased risk of incident hypertension (Forman et al., 2005) . Conceivably, normal blood pressure can be maintained even at sub-optimal 25-(OH)D levels if enough 1,25-(OH) 2 D 3 is produced in renal tubular cells to suppress renin synthesis by a paracrine effect on juxtaglomerular cells. However, this is unlikely to be the case in advancing age, when renal CYP27B1 is no longer under stringent control from the Ca 2 þ /PTH axis (Armbrecht et al., 1999) . In this situation, the amount of available 25-(OH)D will ultimately determine the amount of 1,25-(OH) 2 D 3 that is produced in the kidney, and thus the extent of its anti-hypertensive effect. This inference agrees with a recent report (Judd et al., 2008) that the age-related increase in systolic blood pressure in White Americans having 25-(OH)D serum concentrations above 80 nM was 20% lower than in those with 25-(OH)D levels below 50 nM.
Vitamin D, calcium and chronic diseases M Peterlik and HS Cross
Evidence from a very large number of observational studies and randomized clinical trials indicates that low dietary calcium constitutes a significant risk factor for primary hypertension (McCarron and Reusser, 1999) . Calcium seems to be particularly effective in reducing the age-related increase in blood pressure. Dobnig et al. (2005) conducted a randomized, double-blind, multi-center study on the effect of daily high-dose calcium supplements in healthy, elderly adults and observed a substantial reduction of systolic and diastolic blood pressure after 1 year of treatment in individuals who were in the upper-third of pre-study blood pressure values. No further improvement was seen by calcium plus vitamin D supplementation.
At present it is not known whether changes in dietary calcium affect blood pressure through the action of the CaR on endothelial and smooth vascular cells of human arteries (Molostvov et al., 2007) . Alternatively, activation of the renal CaR leading to enhanced prostaglandin E 2 synthesis and natriuresis with subsequent reduction in plasma volume, may account for the blood pressure-lowering effect of elevated extracellular calcium (Wang et al., 2001) .
Obesity, metabolic syndrome and diabetes mellitus type II 25-(OH)D levels are inversely correlated with body mass index not only in morbidly obese women but also in healthy children, adolescents and adults of both genders (Hypponen and Power, 2007) . A clinical study of calcium intake with a skeletal end point showed significant negative associations between calcium intake and body weight in women aged 30-80 years (Davies et al., 2000) .
Obesity, hypertension, dyslipidemia and glucose intolerance are constituents of the so-called metabolic syndrome and of non-insulin-dependent diabetes mellitus. The key feature here is resistance to insulin action in the classical target organs of the hormone. When leptin and other adipocytokinins are released from adipose tissue, they cause over-stimulation of the central sympathetic nervous system and elevated rates of lipolysis. The resulting free fatty acids interfere with glucose and lipid metabolism in the liver and reduce insulin sensitivity of skeletal muscle cells. A link between insufficiencies in vitamin D and calcium, and the metabolic syndrome and type II diabetes mellitus has been established in many observational studies and clinical trials (reviewed by Pittas et al., 2007) . However, it is not yet known by what mechanism(s) vitamin D and calcium could interfere with induction of insulin resistance at the systemic or at the target cell level: CYP27B1-mediated conversion of 25-(OH)D 3 to 1,25-(OH) 2 D 3 has been observed in liver cells (Negrea et al., 1995) but not in adipose tissues and skeletal muscles. Whether the CaR in hepatocytes (Canaff et al., 2001) and adipocytes (Cifuentes et al., 2005) is involved in modulating insulin sensitivity has not yet been established.
Cardiovascular disease
Vitamin D and calcium insufficiencies have been correlated not only with cardiovascular risk factors, such as obesity, hypertension, metabolic syndrome and diabetes mellitus type II, as detailed before, but also with incident cardiovascular symptoms, including angina, coronary insufficiency, myocardial infarction, transient ischemic attack and stroke (Wang et al., 2008) , as well as with greater mortality from chronic cardiovascular disease (Bostick et al., 1999; Dobnig et al., 2008) .
Cardiomyocytes as well as vascular endothelial and smooth muscle cells express the VDR and are endowed with a functional CaR. However, the mechanisms by which vitamin D and calcium insufficiencies could cause heart failure are poorly understood. In a rat model of cardiac hypertrophy, the cardioprotective effect of 1,25-(OH) 2 D 3 was associated with VDR-mediated suppression of several genes that were upregulated in course of the hypertrophic process (Wu et al., 1996) . Activation of the CaR on rat neonatal ventricular cardiomyocytes had a biphasic effect on DNA, suggesting that the receptor could have a role in maintaining cellular homeostasis (Tfelt-Hansen et al., 2006) .
Vascular endothelial cells convert 25-(OH)D 3 to 1,25-(OH) 2 D 3 (Hewison et al., 2003) , which likely acts in a paracrine fashion on VDR-bearing vascular smooth muscle cells. Therefore, it has been suggested that vitamin D is an important regulator of vascular functions. This view is strongly supported by findings of Wu-Wong et al. (2006) , who identified 176 genes in human coronary artery smooth muscle cells that are sensitive to 1,25-(OH) 2 D 3 , including those involved in regulating smooth muscle cell growth, thrombogenicity, fibrinolysis and endothelial regeneration.
Human smooth muscle and endothelial cells in large and small arteries are equipped with the CaR, but the function of the receptor in the cardiovascular system has not been defined. Molostvov et al. (2007) suggested that arterial calcification, which is a major cause of premature cardiovascular mortality, could be the result of CaR activation. Thus, one cannot exclude that calcium supplementation may cause adverse vascular events that compromise, at least in part, its beneficial action on cardiovascular risk.
Neuromuscular dysfunction
In elderly people with relatively low serum 25-(OH)D, supplementation with either vitamin D or calcium had a significant beneficial effect on postural sway, reaction time and balance, as well as on musculoskeletal functions and physical performance (Pfeifer et al., 2009) . Optimal results were achieved with combined vitamin D and calcium supplementation, which also suggested that improvement of neuromuscular functions was accompanied by the highest decrease in the number of falls (Bischoff-Ferrari et al., 2006b) , which account for roughly one-half of osteoporotic fractures in the elderly.
The mechanisms by which vitamin D and calcium modulate neuromuscular functions are far from being understood. 25-(OH)D-1a-hydroxylase is expressed in neurons and in glial cells in many structures of the central nervous system (Eyles et al., 2005) . The CaR is also widely distributed in the central nervous system (Yano et al., 2004a 
Outlook
Improving the vitamin D and calcium status is a major public health goal in view of the fact that combined vitamin D and calcium insufficiency occurs in about one-quarter of otherwise healthy adults (Peterlik and Cross, 2005) . As vitamin D and calcium insufficiency jointly contribute to the development of chronic diseases, it can be expected that an adequate vitamin D status is required to achieve the nutritional benefits of calcium supplementation and vice versa. Therefore, a deeper understanding of the molecular and cellular processes, by which vitamin D and calcium insufficiency is linked to the pathogenesis of various chronic diseases, will help to advocate and promote adequate measures for improving the vitamin D and calcium status in the general population for the sake of a better health outcome.
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